Effect of recombinant β-defensin 1 protein on human sperm motility and viability
Andrologia Nov 07, 2019
Khayamabed R, et al. - The analysis of semen samples such as sperm concentration, motility, viability, morphology, and semen volume was carried out according to the World Health Organization criteria in order to incubate human processed spermatozoa with recombinant β-defensin 1 (500 ng/ml) for 1, 2 and 3 hr at 37°C under 5% CO2 atmosphere and evaluation of sperm viability and motility in 59 semen samples. The result of the current study exhibited that compared with processed spermatozoa incubate in the absence of β-defensin in the studied time intervals, the incubation of spermatozoa with recombinant β-defensin notably sustained the percentage of sperm viability and motility. In summary, recombinant β-defensin 1 protein as an agent with antimicrobial activity could sustain sperm viability and motility in, in vitro condition.Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
55 lakhs+ doctors trust M3 globally
Unlimited access to original articles by experts
Secure: we never sell your data
Signing up takes less than 2 mins